 | |
| Clinical data | |
|---|---|
| Other names | 5-MeO-MSBT; 5-Methoxy-N-methyl-N-sec-butyltryptamine |
| Routes of administration | Oral [1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 3–4 hours [1] |
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C16H24N2O |
| Molar mass | 260.381 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-MeO-MsBT, also known as 5-methoxy-N-methyl-N-sec-butyltryptamine, is a psychedelic drug of the tryptamine and 5-methoxytryptamine families. [1] [2] It emerged as a novel designer drug online in December 2022. [1] More specifically, its chemical synthesis and the claimed properties and effects of 5-MeO-MsBT were posted on a specialized psychoactive drug forum. [1]
Contents
The dose of the drug is said to be 10 to 30 mg orally and its duration is said to be 3 to 4 hours. [1] Its effects were reported to include a tryptamine-like warmth or fuzzy feeling, tactile and music enhancement, enhanced mood, confusion, mild paranoia, weak psychedelic effects and self-detachment at higher doses, and an antidepressant-like psychedelic afterglow. [1] The afterglow is said to last 12 to 24 hours, with apparent tolerance developing to it with repeated administration over a few days. [1] 5-MeO-MsBT's effects were described as very similar to those of 5-MeO-MiPT at lower doses, but it is less potent than 5-MeO-MiPT and was regarded as inferior in many respects. [1]
The drug has not otherwise been encountered, for instance sold online or in drug seizures, as of 2023. [1]